Herbas VPB

Print
EN | LT
LT - Humanizuoti anti-CD19 antikūnai ir jų panaudojimas navikų transplantacijos ir autoimuninių ligų gydymui
EN - HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF TUMORS, TRANSPLANTATION AND AUTOIMMUNE DISEASES

Legal status

Patent in force

Claims | Licences/Sublicenses
SPA: PA 2022 520
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 39/395 (2006.01)
C07K 16/18 (2006.01)
C07K 16/28 (2006.01)
C12N 15/13 (2006.01)
C12N 5/10 (2006.01)
European patent
(11) Number of the document 2066349
(13) Kind of document T
(96) European patent application number 07842083.3
Date of filing the European patent application 2007-09-07
(97) Date of publication of the European application 2009-06-10
(45) Date of publication and mention of the grant of the patent 2012-03-28
(46) Date of publication of the claims translation 2012-07-25
PCT application
(86) Number PCT/US2007/077916
Date 2007-09-07
PCT application publication
(87) Number WO 2008/031056
Date 2008-03-13
Priority applications
(30) Number Date Country code
842935 P 2006-09-08 US
866917 P 2006-11-22 US
911397 P 2007-04-12 US
915309 P 2007-05-01 US
939429 P 2007-05-22 US
Inventors
(72)
DAMSCHRODER, Melissa, US
KIENER, Peter, US
WU, Herren, US
DALL`ACQUA, William, US
HERBST, Ronald, US
COYLE, Anthony, US
Grantee
(73) Viela Bio, Inc., 1 Horizon Way, Deerfield, Illinois 60015, US
Attorney or representative
(74) Liucija JANICKAITĖ, Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius, LT
Title
(54) Humanizuoti anti-CD19 antikūnai ir jų panaudojimas navikų transplantacijos ir autoimuninių ligų gydymui
  HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF TUMORS, TRANSPLANTATION AND AUTOIMMUNE DISEASES
Last renewal fee
Payment date Validity (years) Amount
2025-08-20 19 347.00 EUR
Next renewal fee
2026-09-07
Last update date 2025-08-21